September 9, 2020 – Thermo Fisher Scientific Inc. (Waltham, MA) announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri.
The facility is adjacent to the company’s biologics manufacturing facility, which recently doubled production capacity with a $50 million expansion.
The company say that the combined expertise from Thermo Fisher’s bioproduction and pharma services businesses will accelerate innovation and enhance productivity for biopharma companies, enabling them to meet the growing need for more flexible, scalable biologics development and manufacturing solutions.
“The BCC will bring together the company’s leadership in GMP biologics manufacturing with its deep expertise in bioprocessing technologies including bioreactors, cell culture media, chromatography and analytical tools, among others. This collaboration will deliver new single-use bioprocessing technologies as well as drive critical process, data management and quality improvements that enable scale-up solutions for biopharma customers,” Thermo Fisher said.